Management of arrhythmias due to accessory conduction pathways.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000503:physiopathology / Q000628:therapy*; D006328:Cardiac Catheterization / Q000379:methods; D004562:Electrocardiography / Q000379:methods; D006327:Heart Block / Q000503:physiopathology / Q000628:therapy; D006329:Heart Conduction System / Q000503:physiopathology* / Q000601:surgery; D006801:Humans; D010138:Pacemaker, Artificial; D013610:Tachycardia / Q000503:physiopathology; D014927:Wolff-Parkinson-White Syndrome / Q000503:physiopathology / Q000628:therapy*
D000889:Anti-Arrhythmia Agents